PTJ
TYRA icon

Paul Tudor Jones’s Tyra Biosciences TYRA Stock Holding History

Paul Tudor Jones’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,284
Closed -$624K – 4296
2026
Q1 		$624K Buy
+16,284
New +$527K ﹤0.01% 2674
2025
Q4 		– Sell
-10,761
Closed -$151K – 4070
2025
Q3 		$151K Sell
10,761
-15,504
-59% -$177K ﹤0.01% 3235
2025
Q2 		$251K Buy
26,265
+14,172
+117% +$135K ﹤0.01% 2977
2025
Q1 		$112K Sell
12,093
-3,484
-22% -$45.1K ﹤0.01% 2934
2024
Q4 		$217K Sell
15,577
-10,769
-41% -$195K ﹤0.01% 2788
2024
Q3 		$619K Buy
+26,346
New +$553K ﹤0.01% 1903

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Paul Tudor Jones's TYRA Position: Q2 2026 in Review

Paul Tudor Jones sold out of Tyra Biosciences (TYRA) in Q2 2026, closing a stake of 16,284 shares — an estimated $624K sold.

Paul Tudor Jones first reported a position in TYRA in Q3 2024 and held it in 6 quarters. The position peaked at $624K in Q1 2026. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Paul Tudor Jones reported no remaining Tyra Biosciences position as of Q2 2026 after selling out during the quarter.
  • Paul Tudor Jones sold 16,284 Tyra Biosciences shares in Q2 2026, an estimated $624K.
  • Paul Tudor Jones first reported a position in Tyra Biosciences in Q3 2024 and held it in 6 quarters.
  • Paul Tudor Jones's Tyra Biosciences position peaked at $624K in Q1 2026.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.